Your browser doesn't support javascript.
loading
CRISPR/Cas9: molecular tool for gene therapy to target genome and epigenome in the treatment of lung cancer.
Sachdeva, M; Sachdeva, N; Pal, M; Gupta, N; Khan, I A; Majumdar, M; Tiwari, A.
Afiliação
  • Sachdeva M; School of Biotechnology, Rajiv Gandhi Proudyogiki Vishwavidyalya, Bhopal, India.
  • Sachdeva N; Padmashree Dr DY Patil Vidyapeeth's Department of Biotechnology and Bioinformatics, Mumbai, Maharashtra, India.
  • Pal M; School of Biotechnology, Rajiv Gandhi Proudyogiki Vishwavidyalya, Bhopal, India.
  • Gupta N; School of Biotechnology, Rajiv Gandhi Proudyogiki Vishwavidyalya, Bhopal, India.
  • Khan IA; School of Biotechnology, Rajiv Gandhi Proudyogiki Vishwavidyalya, Bhopal, India.
  • Majumdar M; School of Biotechnology, Rajiv Gandhi Proudyogiki Vishwavidyalya, Bhopal, India.
  • Tiwari A; School of Biotechnology, Rajiv Gandhi Proudyogiki Vishwavidyalya, Bhopal, India.
Cancer Gene Ther ; 22(11): 509-17, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26494554

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Sistemas CRISPR-Cas / Neoplasias Pulmonares Limite: Animals / Humans Idioma: En Revista: Cancer Gene Ther Assunto da revista: GENETICA MEDICA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Genética / Sistemas CRISPR-Cas / Neoplasias Pulmonares Limite: Animals / Humans Idioma: En Revista: Cancer Gene Ther Assunto da revista: GENETICA MEDICA / NEOPLASIAS / TERAPEUTICA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Índia